{
    "Case ID": "040343",
    "Different Crime": [
        {
            "Crime Name": "unknown",
            "Crime Type": "others",
            "patent_validity": [
                "Claim 22 of the '493 patent is not eligible for inclusion on the register"
            ],
            "relevant_rule": [
                "Section 6(5)(a) of the Patented Medicines (Notice of Compliance) Regulations"
            ],
            "application_details": [
                "The court analyzed whether claim 22, which refers to the R(+) enantiomer of amlodipine, could be listed against a notice of compliance for the racemate (amlodipine besylate)"
            ],
            "evidence_presented": [
                "The evidence showed that the medicine in the notice of compliance was the racemate, not the isolated enantiomer"
            ],
            "decision_reasoning": [
                "The motion to strike out the proceedings related to the '493 patent was allowed because claim 22 claims the R(+) enantiomer, while the notice of compliance covers the racemate"
            ],
            "cost_awards": [
                "awarded costs to Cobalt Pharmaceuticals"
            ],
            "result_of_case": [
                "struck out the proceedings related to the '493 patent"
            ]
        }
    ]
}